Vyvgart Uniunea Europeană - română - EMA (European Medicines Agency)

vyvgart

argenx - efgartigimod alfa - myasthenia gravis - imunosupresoare - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.

Elfabrio Uniunea Europeană - română - EMA (European Medicines Agency)

elfabrio

chiesi farmaceutici s.p.a - pegunigalsidase alfa - boala fabry - alte medicamente pentru tractul digestiv și metabolism, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).